AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metorgliz 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Health Guard India Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Metorgliz 80mg/500mg Tablet

DiabetaComb 80mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. DiabetaComb 80mg/500mg should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical guidance can elevate blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Maintaining regular meals and carrying a readily available fast-acting glucose source (e.g., sugary snacks or juice) is vital. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (to check blood cell counts and liver function) are recommended.

Primary Ingredients of Metorgliz 80mg/500mg Tablet

The provided text is "undefined," which lacks meaning and cannot be rephrased.

Uses of Metorgliz 80mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Metorgliz 80mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or breaking it. The Metorgliz 80mg/500mg Tablet should be administered with food.

Common Side effects of Metorgliz 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Metorgliz 80mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; do not chew, crush, or fracture it. The Metorgliz 80mg/500mg Tablet should be taken with a meal.

How Metorgliz 80mg/500mg Tablet works:

Each Metorgliz 80mg/500mg tablet contains gliclazide and metformin, two medications used to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Metorgliz 80mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Metorgliz 80mg/500mg tablets during pregnancy poses a confirmed risk to the fetus. A physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Metorgliz 80mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metorgliz 80mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Metorgliz 80mg/500mg tablet use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Metorgliz 80mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation should be at a low dose; however, the medication is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Metorgliz 80mg/500mg Tablet :

Should you forget a Metorgliz 80mg/500mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metorgliz 80mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes medication

FAQs on Metorgliz 80mg/500mg Tablet

Metorgliz 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Metorgliz 80mg/500mg tablets may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Metorgliz 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Metorgliz 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). This rare side effect is less likely in patients without kidney disease, who are not elderly, and who don't consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Metorgliz 80mg/500mg Tablets and seek immediate medical attention.
Prolonged Metorgliz 80mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Metorgliz 80mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Metorgliz 80mg/500mg tablets with alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Metorgliz 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This treatment improves blood sugar control when combined with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Metorgliz 80mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Metorgliz 80mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Metorgliz 80mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This rare side effect is preventable by avoiding use in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Metorgliz 80mg/500mg Tablets and seek immediate medical attention.
Prolonged use of Metorgliz 80mg/500mg tablets can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some studies.
Metorgliz 80mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also be avoided in individuals with moderate to severe kidney disease or metabolic acidosis, such as diabetic ketoacidosis.
Combining Metorgliz 80mg/500mg tablets with alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Metorgliz 80mg/500mg Tabl...
43
MRP 50
14% off